Dr Bakul Gupta is the CEO and Co-founder of Deliver Biosciences, a preclinical stage biotech which is developing safe, scalable and affordable therapies to provide equitable access to curative treatments. The company leverages its nanoparticle based delivery platform to create therapies directly inside patients (in vivo). The lead product is a cell therapy for patients suffering from cancer. Bakul founded the company in 2019, along with her business partner, Dr George Tetley after a 6-month long research into the challenges faced by current cell and gene therapy companies. She completed her Postdoctoral fellowship at Imperial College London, and holds a PhD and BSc in Nanotechnology and Chemistry from UNSW Australia.
She has over 10 years of experience in designing nano- and biomaterials for a diverse set of biomedical applications and has previous experience in commercialisation of medical devices. She was recently awarded the Purple Plaque by the UK's leading innovation agency, Innovate UK and Imperial College London and has been listed as one of the Top 30 biotech entrepreneurs in the UK.